These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 35426890)

  • 1. Sotrovimab for Treatment of COVID-19 in Solid Organ Transplant Recipients.
    Dhand A; Okumura K; Wolfe K; Lobo SA; Nog R; Keller M; Bodin R; Singh N; Levine A; Nabors C
    Transplantation; 2022 Jul; 106(7):e336-e337. PubMed ID: 35426890
    [No Abstract]   [Full Text] [Related]  

  • 2. Sotrovimab in Solid Organ Transplant Patients With Early, Mild/Moderate SARS-CoV-2 Infection: A Single-center Experience.
    Pinchera B; Buonomo AR; Scotto R; Carrano R; Salemi F; Galluccio F; Guarino M; Viceconte G; Schiano Moriello N; Giaccone A; Gallicchio A; Zappulo E; Villari R; Gentile I;
    Transplantation; 2022 Jul; 106(7):e343-e345. PubMed ID: 35349534
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch.
    Yetmar ZA; Beam E; O'Horo JC; Seville MT; Brumble L; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Aug; 24(4):e13901. PubMed ID: 35848574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge.
    Radcliffe C; Palacios CF; Azar MM; Cohen E; Malinis M
    Am J Transplant; 2022 Oct; 22(10):2458-2463. PubMed ID: 35583664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term Outcomes in a Nurse Coordinator-led and Nurse Practitioner-led Sotrovimab Initiative for Solid Organ Transplant Recipients During the Omicron Surge.
    Cochran W; Langlee J; Barker L; Freed K; Brown A; McDade H; Carter D; Boyer L; Sullivan S; Shagena K; Belden M; Marino R; Adams E; Lee J; McCarthy M; Lee-Young K; Ellis S; Young S; Morrison M; Penny CC; Al Ammary F; Hartman L; Horn J; Miller T; Miller S; Purekal S; Siddiqui Z; Segev DL; Brennan DC; Shah P; Avery RK
    Transplantation; 2022 Sep; 106(9):e424-e425. PubMed ID: 35675440
    [No Abstract]   [Full Text] [Related]  

  • 6. Sotrovimab Use for COVID-19 Infection in Pregnant Kidney Transplant Recipient.
    AlKindi F; Chaaban A; Al Hakim M; Boobes Y
    Transplantation; 2022 May; 106(5):e277-e278. PubMed ID: 35135972
    [No Abstract]   [Full Text] [Related]  

  • 7. Sotrovimab therapy in solid organ transplant recipients with mild to moderate COVID-19: a systematic review and meta-analysis.
    Farhadian N; Farhadian M; Zamanian MH; Taghadosi M; Vaziri S
    Immunopharmacol Immunotoxicol; 2023 Dec; 45(4):402-408. PubMed ID: 36537311
    [No Abstract]   [Full Text] [Related]  

  • 8. A Programmatic Response, Including Bamlanivimab or Casirivimab-imdevimab Administration, Reduces Hospitalization and Death in COVID-19 Positive Abdominal Transplant Recipients.
    Ahearn AJ; Thin Maw T; Mehta R; Emamaullee J; Kim J; Blodget E; Kahn J; Sher L; Genyk Y
    Transplantation; 2022 Feb; 106(2):e153-e157. PubMed ID: 34519680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection.
    Weber SC; Danne F; Kieslich M; Krauss A; Berger F; Sallmon H
    J Heart Lung Transplant; 2022 Aug; 41(8):1124-1126. PubMed ID: 35697603
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter.
    Pereira MR; Mohan S; Cohen DJ; Husain SA; Dube GK; Ratner LE; Arcasoy S; Aversa MM; Benvenuto LJ; Dadhania DM; Kapur S; Dove LM; Brown RS; Rosenblatt RE; Samstein B; Uriel N; Farr MA; Satlin M; Small CB; Walsh TJ; Kodiyanplakkal RP; Miko BA; Aaron JG; Tsapepas DS; Emond JC; Verna EC
    Am J Transplant; 2020 Jul; 20(7):1800-1808. PubMed ID: 32330343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early treatment with sotrovimab monoclonal antibody in kidney transplant recipients with Omicron infection.
    Chavarot N; Melenotte C; Amrouche L; Rouzaud C; Sberro-Soussan R; Pavie J; Martinez F; Pouvaret A; Leruez-Ville M; Cantin D; Fourgeaud J; Delage C; Vimpere D; Peraldi MN; Legendre C; Lanternier F; Zuber J; Scemla A; Anglicheau D
    Kidney Int; 2022 Jun; 101(6):1290-1293. PubMed ID: 35421508
    [No Abstract]   [Full Text] [Related]  

  • 12. Casirivimab-imdevimab to Prevent SARS-CoV-2 Infections in Solid Organ Transplant Recipients.
    Dimeglio C; Del Bello A; Chapuy-Regaud S; Esposito L; Danet C; Couat C; Izopet J; Kamar N
    Transplantation; 2022 May; 106(5):e275-e276. PubMed ID: 35283456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bamlanivimab for treatment of COVID-19 in solid organ transplant recipients: Early single-center experience.
    Dhand A; Lobo SA; Wolfe K; Feola N; Nabors C
    Clin Transplant; 2021 Apr; 35(4):e14245. PubMed ID: 33595145
    [No Abstract]   [Full Text] [Related]  

  • 14. Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients.
    Mendoza MA; Razonable RR
    Infect Dis Clin North Am; 2023 Sep; 37(3):475-493. PubMed ID: 37142512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Acquisition of COVID-2019 Neutralizing Antibodies in Organ Transplant Recipients.
    Akimoto S; Onoe T; Morimoto H; Yamaguchi S; Shibata Y; Tazuma S; Sada H; Shimada N; Tazawa H; Suzuki T; Sudo T; Shimizu Y; Tashiro H
    Transplant Proc; 2023 May; 55(4):815-819. PubMed ID: 37147198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients.
    Shertel T; Lange NW; Salerno DM; Hedvat J; Jennings DL; Choe JY; Brown RS; Pereira MR
    Transplantation; 2022 Oct; 106(10):e463-e464. PubMed ID: 35939386
    [No Abstract]   [Full Text] [Related]  

  • 17. Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients.
    Yetmar ZA; Bhaimia E; Razonable RR
    Curr Opin Organ Transplant; 2022 Aug; 27(4):269-276. PubMed ID: 36354253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
    Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 therapeutics and outcomes among solid organ transplant recipients during the Omicron BA.1 era.
    Hedvat J; Lange NW; Salerno DM; DeFilippis EM; Kovac D; Corbo H; Chen JK; Choe JY; Lee JH; Anamisis A; Jennings DL; Codispodo G; Shertel T; Brown RS; Pereira MR
    Am J Transplant; 2022 Nov; 22(11):2682-2688. PubMed ID: 35801839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-SARS-CoV-2 Monoclonal Antibodies in Solid-organ Transplant Patients.
    Del Bello A; Marion O; Vellas C; Faguer S; Izopet J; Kamar N
    Transplantation; 2021 Oct; 105(10):e146-e147. PubMed ID: 34224543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.